Rapid binding of electrostatically stabilized iron oxide nanoparticles to THP-1 monocytic cells via interaction with glycosaminoglycans

Basic Research in Cardiology

Volumn 108, Issue 2, 2013, Pages

  Ludwig, Antje ^a   Poller, Wolfram C ^a   Westphal, Kera ^a   Minkwitz, Susann ^a   Lättig Tünnemann, Gisela ^a   Metzkow, Susanne ^a   Stangl, Karl ^a   Baumann, Gert ^a   Taupitz, Matthias ^a   Wagner, Susanne ^a   Schnorr, Jörg ^a   Stangl, Verena ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Atherosclerosis; Cytotoxicity; Glycosaminoglycans; Iron oxide particles; Macrophages; Magnetic resonance imaging

Indexed keywords

CASPASE 3; CHONDROITIN ABC LYASE; CITRIC ACID; CXCL11 CHEMOKINE; FERUCARBOTRAN; GLUCOSE; GLYCOSAMINOGLYCAN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA; CONTRAST MEDIUM; DEXTRAN; MAGNETITE NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BINDING AFFINITY; BINDING KINETICS; CARBOHYDRATE SYNTHESIS; CELL FUNCTION; CELL INTERACTION; CELL MEMBRANE; CELL PROLIFERATION; CELL SURFACE; CELL VACUOLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MONOCYTE; NUCLEAR MAGNETIC RESONANCE IMAGING; CELL LINE; CHEMISTRY; ELECTRON MICROSCOPY; METABOLISM;

CELL LINE; CONTRAST MEDIA; DEXTRANS; GLYCOSAMINOGLYCANS; HUMANS; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICROSCOPY, ELECTRON; MONOCYTES; PLAQUE, ATHEROSCLEROTIC;

MLCS; MLOWN;

EID: 84872080927     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-013-0328-2     Document Type: Article

References (40)

1. Cechowska-Pasko M, Bankowski E (2010) Glucose deficiency inhibits glycosaminoglycans synthesis in fibroblast cultures. Biochimie 92:806-813. doi:10.1016/j.biochi.2010.02.029
2. Howarth SP, Tang TY, Trivedi R, Weerakkody R, King-Im J, Gaunt ME, Boyle JR, Li ZY, Miller SR, Graves MJ, Gillard JH (2009) Utility of USPIO-enhanced MR imaging to identify inflammation and the fibrous cap: a comparison of symptomatic and asymptomatic individuals. Eur J Radiol 70:555-560. doi: 10.1016/j.ejrad.2008.01.047
3. Hu F, Neoh KG, Cen L, Kang ET (2006) Cellular response to magnetic nanoparticles ''PEGylated'' via surface-initiated atom transfer radical polymerization. Biomacromolecules 7:809-816. doi:10.1021/bm050870e (Pubitemid 44055908)
4. Klein NJ, Shennan GI, Heyderman RS, Levin M (1992) Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils. J Cell Sci 102:821-832
5. Kockx MM (1998) Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. Arterioscler Thromb Vasc Biol 18:1519-1522. doi:10.1161/01.ATV.18.10.1519 (Pubitemid 28465401)
6. Kolodgie FD, Burke AP, Farb A, Weber DK, Kutys R, Wight TN, Virmani R (2002) Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thromb Vasc Biol 22:1642-1648. doi:10.1161/01.ATV. 0000034021.92658.4C
7. Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M, Frederik PM, Daemen MJ, van Engelshoven JM (2003) Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107:2453-2458. doi:10.1161/01.CIR.0000068315.98705.CC (Pubitemid 36605228)
8. Kresse M, Lawaczeck R, Pfefferer D (1995) Nanocrystalline magnetic iron oxide particles-method for preparation and use in medical diagnostics and therapy. US Patent 5427767
9. Krpetic Z, Nativo P, Prior IA, Brust M (2011) Acrylate-facilitated cellular uptake of gold nanoparticles. Small 7:1982-1986. doi: 10.1002/smll.201100462
10. Kruse R, Merten M, Yoshida K, Schmidt A, Völker W, Buddecke E (1996) Cholesterol-dependent changes of glycosaminoglycan pattern in human aorta. Basic Res Cardiol 91:344-352 (Pubitemid 26373552)
11. Lewis CE, McGee JO (1992) The natural immune system: the macrophage. Oxford University Press, New York
12. Libby P, Geng YJ, Sukhova GK, Simon DI, Lee RT (1997) Molecular determinants of atherosclerotic plaque vulnerability. Ann N Y Acad Sci 811:134-142. doi:10.1111/j.1749-6632
13. Makatsori E, Lamari FN, Theocharis AD, Anagnostides S, Hjerpe A, Tsegenidis T, Karamanos N (2003) Large matrix proteoglycans, versican and perlecan, are expressed and secreted by human leukemic monocytes. Anticancer Res 23:3303-3309 (Pubitemid 36975427)
14. Makowski MR, Varma G, Wiethoff AJ, Smith A, Mattock K, Jansen CH, Warley A, Taupitz M, Schaeffter T, Botnar RM (2011) Noninvasive assessment of atherosclerotic plaque progression in ApoE-/- mice using susceptibility gradient mapping. Circ Cardiovasc Imaging 3:295-303. doi:10.1161/CIRCIMAGING.110. 957209
15. Martinet W, Schrijvers DM, De Meyer GR (2012) Molecular and cellular mechanisms of macrophage survival in atherosclerosis. Basic Res Cardiol 107:297. doi:10.1007/s00395-012-0297-x
16. Martinet W, Schrijvers DM, De Meyer GR (2011) Necrotic cell death in atherosclerosis. Basic Res Cardiol 106:749-760. doi: 10.1007/s00395-011-0192-x
17. Montoro-García S, Shantsila E, Marín F, Blann A, Lip GY (2011) Circulating microparticles: new insights into the biochemical basis of microparticle release and activity. Basic Res Cardiol 106:911-923. doi:10.1007/s00395-011-0198-4
18. Meiners S, Ludwig A, Lorenz M, Dreger H, Baumann G, Stangl V, Stangl K (2006) Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cells. Free Radic Biol Med 40:2232-2241. doi:10.1016/j.freeradbiomed. 2006.03.003 (Pubitemid 43922398)
19. Muller K, Skepper JN, Tang TY, Graves MJ, Patterson AJ, Corot C, Lancelot E, Thompson PW, Brown AP, Gillard JH (2008) Atorvastatin and uptake of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) in human monocyte-macrophages: implications for magnetic resonance imaging. Biomaterials 29:2656-2662. doi:10.1016/j.biomaterials.2008.03.006
20. Pilgrimm H (2007) Aqueous dispersions of superparamagnetic single domain particles production and use thereof for diagnosis and therapy. Patent PCT/EP2006/069453[WO/2007/065935]
21. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C (2004) Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 39:56-63. doi:10.1097/01.rli. 0000101027.57021.28 (Pubitemid 38030177)
22. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809. doi:10.1038/362801a0 (Pubitemid 23132154)
23. Schmitz SA, Taupitz M, Wagner S, Wolf KJ, Beyersdorff D, Hamm B (2001) Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J Magn Reson Imaging 14:355-361. doi:10.1002/jmri.1194 (Pubitemid 32906552)
24. Schmitz SA, Winterhalter S, Schiffler S, Gust R, Wagner S, Kresse M, Coupland SE, Semmler W, Wolf KJ (2001) USPIO-enhanced direct MR imaging of thrombus: preclinical evaluation in rabbits. Radiology 221:237-243. doi:10.1148/radiol.2211001632 (Pubitemid 32880395)
25. Sigovan M, Boussel L, Sulaiman A, Sappey-Marinier D, Alsaid H, Desbleds-Mansard C, Ibarrola D, Gamondes D, Corot C, Lancelot E, Raynaud JS, Vives V, Lacledere C, Violas X, Douek PC, Canet-Soulas E (2009) Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model. Radiology 252:401-409. doi: 10.1148/radiol. 2522081484
26. Soenen SJ, Himmelreich U, Nuytten N, De Cuyper M (2011) Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. Biomaterials 32:195-205. doi: 10.1016/j.biomaterials.2010.08.075
27. Soenen SJ, Illyes E, Vercauteren D, Braeckmans K, Majer Z, De Smedt SC, De Cuyper M (2009) The role of nanoparticle concentration- dependent induction of cellular stress in the internalization of non-toxic cationic magnetoliposomes. Biomaterials 30:6803-6813. doi:10.1016/j.biomaterials.2009.08. 050
28. Soenen SJ, Nuytten N, De Meyer SF, De Smedt SC, De Cuyper M (2010) High intracellular iron oxide nanoparticle concentrations affect cellular cytoskeleton and focal adhesion kinasemediated signaling. Small 6:832-842. doi:10.1002/smll.20090 2084
29. Sosnovik DE, Nahrendorf M, Weissleder R (2008) Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications. Basic Res Cardiol 103:122-130. doi: 10.1007/s00395-008-0710-7 (Pubitemid 351356755)
30. Tang TY, Howarth SP, Miller SR, Graves MJ, Patterson AJ, U-King-Im JM, Li ZY, Walsh SR, Brown AP, Kirkpatrick PJ, Warburton EA, Hayes PD, Varty K, Boyle JR, Gaunt ME, Zalewski A, Gillard JH (2009) The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxideenhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol 53:2039-2050. doi:10.1016/j.jacc.2009.03.018
31. Tang TY, Muller KH, Graves MJ, Li ZY, Walsh SR, Young V, Sadat U, Howarth SP, Gillard JH (2009) Iron oxide particles for atheroma imaging. Arterioscler Thromb Vasc Biol 29:1001-1008. doi:10.1161/ATVBAHA.108.165514
32. Taupitz M, Wagner S, Schnorr J, Kravec I, Pilgrimm H, Bergmann-Fritsch H, Hamm B (2004) Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging. Invest Radiol 39:394-405. doi:10.1097/01.rli. 00001294 72.45832.b0 (Pubitemid 38802814)
33. Trivedi RA, Mallawarachi C, U-King-Im JM, Graves MJ, Horsley J, Goddard MJ, Brown A, Wang L, Kirkpatrick PJ, Brown J, Gillard JH (2006) Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol 26:1601-1606. doi:10.1161/01. ATV.0000222920.59760.df (Pubitemid 44288989)
34. Trivedi RA, U-King-Im JM, Graves MJ, Kirkpatrick PJ, Gillard JH (2004) Noninvasive imaging of carotid plaque inflammation. Neurology 63:187-188. doi:10.1212/01.WNL. 0000132962.12841.1D (Pubitemid 38943809)
35. Van Herck JL, De Meyer GR, Martinet W, Salgado RA, Shivalkar B, De Mondt R, Van De Ven H, Ludwig A, Van Der Veken P, Van Vaeck L, Bult H, Herman AG, Vrints CJ (2010) Multi-slice computed tomography with N1177 identifies ruptured atherosclerotic plaques in rabbits. Basic Res Cardiol 105:51-59. doi:10.1007/s00395-009-0052-0
36. Vats N, Wilhelm C, Rautou PE, Poirier-Quinot M, Pechoux C, Devue C, Boulanger CM, Gazeau F (2010) Magnetic tagging of cell-derived microparticles: new prospects for imaging and manipulation of these mediators of biological information. Nanomedicine (Lond) 5:727-738. doi:10.2217/nnm.10.44
37. Wagner M, Wagner S, Schnorr J, Schellenberger E, Kivelitz D, Krug L, Dewey M, Laule M, Hamm B, Taupitz M (2011) Coronary MR angiography using citrate-coated very small superparamagnetic iron oxide particles as blood-pool contrast agent: initial experience in humans. J Magn Reson Imaging 34:816-823. doi:10.1002/jmri.22683
38. Wagner S, Schnorr J, Pilgrimm H, Hamm B, Taupitz M (2002) Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization. Invest Radiol 37:167-177 (Pubitemid 34259726)
39. Whiteman P (1973) The quantitative measurement of Alcian Blue-glycosaminoglycan complexes. Biochem J 131:343-350
40. Yamagata T, Saito H, Habuchi O, Suzuki S (1968) Purification and properties of bacterial chondroitinases and chondrosulfatases. J Biol Chem 243:1523-1535